Last Updated : April 15, 2008
Details
FilesGeneric Name:
Adalimumab
Project Status:
Complete
Therapeutic Area:
Psoriasis
Manufacturer:
Abbott Laboratories, Limited
Brand Name:
Humira
Project Line:
Reimbursement Review
Project Number:
SR0130-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Psoriasis
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : April 15, 2008